IP77-12: Using ex vivo culture to evaluate dynamic changes in the bladder and prostate tumor microenvironment following durvalumab treatment.
Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147A
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!